Lab data

Tesamorelin test results: how often vials pass lab testing

Tesamorelin is an approved drug, and research vials sold under its name failed almost as often as they passed. An approved name on a label carries none of the approval.

12 November 2026 3 min read By Peptide AI Editorial policy

Of the last 190 Tesamorelin samples with a result in Finnrick's public lab-testing database, 100 passed and 90 failed: 53 percent of Tesamorelin test results were a pass. Another 10 came back incomplete and are left out. Finnrick has published 764 Tesamorelin tests from 114 sellers since 7 May 2025.

Tesamorelin is a stabilised GHRH analog and one of the few compounds in our library with full FDA approval. It was approved in 2010 as Egrifta to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy. The tests here are of research-labelled tesamorelin, which is not Egrifta.

The short version

  • 53 percent of recent samples passed. 100 passed and 90 failed, of the last 190 with a result.
  • It is FDA-approved as Egrifta, for a narrow indication. A research-labelled vial is not Egrifta.
  • A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
  • We do not name sellers. The numbers describe the market, not any one shop.

Tesamorelin test results in numbers

MeasureTesamorelin
Published tests764
Sellers with at least one test114
First and latest test7 May 2025 to 6 Nov 2026
Recent results counted190 (10 incomplete left out)
Passed100
Failed90
Pass rate53%
Rank by pass rate10 of 14 on our peptide test results page

Figures from Finnrick's public Tesamorelin page, checked on 12 November 2026. They will change as new results come in.

What counts as a pass or a fail

These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.

The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.

Is tesamorelin FDA-approved?

Yes. Tesamorelin is sold as Egrifta, and later formulations (Egrifta SV and a weekly-reconstitution version) have also been approved (see our tesamorelin page). The approval covers that product, made by its manufacturer. It does not extend to a vial of powder sold online with the same name on it.

An approved drug, and half the research vials failed

Of the last 190 tesamorelin samples with a result, 100 passed and 90 failed. Another 10 came back incomplete, the most of any compound on our list. That puts tesamorelin near the bottom of the 14 on our peptide test results page, below compounds that have never been approved.

The lesson carries beyond tesamorelin. Approval belongs to a product, not to a molecule. Finnrick has published 764 tesamorelin tests from 114 sellers since 7 May 2025.

Before you buy Tesamorelin

Tesamorelin is an approved medicine, so a prescription filled by a licensed pharmacy is the safer route. Peptide AI's prescription route through licensed telehealth is coming soon.

Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.

Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.

Questions people ask

What percentage of Tesamorelin fails lab testing?

In Finnrick's public test database, 90 of the last 190 Tesamorelin samples with a result failed, which is 47 percent, and 100 passed. Tests that came back incomplete are left out.

Is Tesamorelin FDA-approved?

It is FDA-approved as Egrifta, for a narrow indication. A research-labelled vial is not Egrifta.

Does a passing lab test mean Tesamorelin is safe?

No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Tesamorelin is safe or does anything in people.

Is research tesamorelin the same as Egrifta?

No. Egrifta is the approved product, made and released under drug manufacturing rules. A research-labelled vial uses the same name, and 90 of the last 190 tested samples failed.

Sources

  1. Methodology, Finnrick, accessed 12 November 2026
  2. Tesamorelin product page and public test history, Finnrick, accessed 12 November 2026
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.